According to Tianyan App, on December 28, Medical AI Co., Ltd. added a piece of financing information to Dukun (Beijing) Network Technology Co., Ltd., with a transaction amount of 590 million yuan. Investors include Sequoia Capital China, China re Capital, China Jin Pucheng, Huagai Capital, Wuyuan Capital, QiMing Venture Partners and so on.

According to 36Kr Holdings, this round of financing will be used to increase investment in research and development of original technology, continuously improve the product line of core technology of "digital human body", further speed up the landing and deployment of products in medical institutions at all levels, and accelerate the comprehensive coverage of digital medical productivity in the process of intelligent construction of hospitals across the country.

Jukun (Beijing) Network Technology Co., Ltd. was established in June 2017 with a registered capital of about 7.378 million yuan. The legal representative is Ma Chune, founder and CEO of the company. Tianyan check App shows that the company's chairman Mao Xinsheng holds 21.86% of the shares, which is the largest shareholder and suspected actual controller of the company; Ma Chune directly holds 14.74%, the second largest shareholder, plus 5.49% indirect shares, a total of 20.23%.

According to App, Jukun Technology has gone through six rounds of financing, and before this round, it has completed two rounds of financing this year, namely, the B+ round completed in June and the strategic financing completed in August, each raising Rmb200m, while the company raised nearly RMB 1 billion this year. Angel's round B financing was completed from 2017 to 2019, with financing amounts of RMB 22 million, 100m and 200m respectively. The main investors included Yuanyi Capital, Wuyuan Capital and Huagai Capital, all of which participated in more than two rounds of financing.